Clinical and PET/CT metabolic imaging characteristics across the evolving spectrum of visceral leishmaniasis and associated hemophagocytic lymphohistiocytosis - Quiz - MDSpire

Clinical and PET/CT metabolic imaging characteristics across the evolving spectrum of visceral leishmaniasis and associated hemophagocytic lymphohistiocytosis

  • By

  • Chao Yang

  • Yan Wang

  • Ruixian Duan

  • Feiyan Wei

  • Xiu Sun

  • July 13, 2026

Share

Original Source(s)

Clinical and PET/CT metabolic imaging characteristics across the evolving spectrum of visceral leishmaniasis and associated hemophagocytic lymphohistiocytosis

  • by Chao Yang, Yan Wang, Ruixian Duan, Feiyan Wei, Xiu Sun

  • July 13, 2026

Related Content

Pre–existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18–30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data

Performance evaluation of five major large language models in tuberculosis Q&A systems: A multidimensional assessment of readability, quality, and reliability

Pathogen effects on the brain: the case of SARS-CoV-2 spike protein and neuro COVID